Fisher buys BioServices in $60M deal

McKesson is selling Rockville, Maryland-based BioServices -- a clinical-trial supply business -- to Fisher Scientific for $60 million. The operation has about $50 million in annual sales in biological specimens and trial materials.

- read this story from the San Francisco Business Times

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.